SIREN : 918013152
CCD BIOES SANTE is a French company founded 3 years ago, specialized in the sector Études de marché et sondages. Based in PARIS (75017), this company of category ETI shows in 2024 a revenue of 6.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 5 955 671 € | 5 268 198 € | 1 566 577 € |
| Net income | 170 596 € | 156 304 € | 55 452 € |
| EBITDA | 105 623 € | 6 299 € | 19 729 € |
| Net margin | 2.9% | 3.0% | 3.5% |
In 2024, CCD BIOES SANTE achieves revenue of 6.0 M€. Over the period 2022-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +95.0%. Vs 2023, growth of +13% (5.3 M€ -> 6.0 M€). After deducting consumption (111 k€), gross margin stands at 5.8 M€, i.e. a rate of 98%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 106 k€, representing 1.8% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 171 k€, i.e. 2.9% of revenue. This profit can be retained or distributed to shareholders.
5 955 671 €
5 844 310 €
105 623 €
289 511 €
170 596 €
1.8%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 20%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
0.117%
19.675%
-0.223%
0.0
In 2024, the debt ratio of CCD BIOES SANTE (0.12) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of CCD BIOES SANTE (19.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of CCD BIOES SANTE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 124.49. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.0x. Danger: operating income does not cover interest charges, unsustainable situation.
124.494
0.001
In 2024, the liquidity ratio of CCD BIOES SANTE (124.49) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of CCD BIOES SANTE (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 42 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 23 days. The company must finance 19 days of gap between collections and payments. Overall, WCR represents 26 days of revenue, i.e. 427 k€ to permanently finance. Over 2022-2024, WCR increased by +112%, requiring additional financing.
427 200 €
42 j
23 j
0 j
26 j
Based on 107 transactions of similar company sales (all years), the value of CCD BIOES SANTE is estimated at 634 980 € (range 246 765€ - 1 259 257€). With an EBITDA of 105 623€, the sector multiple of 2.6x is applied. The price/revenue ratio is 0.23x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 107 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare CCD BIOES SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Études de marché et sondages
The revenue of CCD BIOES SANTE in 2024 is 6.0 M€.
Yes, CCD BIOES SANTE generated a net profit of 171 k€ in 2024.
The headquarters of CCD BIOES SANTE is located in PARIS (75017), in the department Paris.
The tax return of CCD BIOES SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
CCD BIOES SANTE operates in the sector Études de marché et sondages (NAF code 73.20Z). See the 'Sector positioning' section above to compare the company with its competitors.